Attention: World-2DPAGE is no longer maintained. Previously submitted data can still be queried at World-2DPAGE Repository.
[Click to access protein entry]
Spot: 2D-001VO0 (nucleoli_hela_2d_human)
pI: 6.15 Mw: 43488
%vol: 0.249195 %od: 0.18991
================
*RRS1_HUMAN*
accession n°: Q15050
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001VO0 (nucleoli_hela_2d_human)
pI: 6.15 Mw: 43488
%vol: 0.249195 %od: 0.18991
================
*RRS1_HUMAN*
accession n°: Q15050
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VJW (nucleoli_hela_2d_human)
pI: 5.27 Mw: 57216
%vol: 0.412628 %od: 0.64234
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 870.4 (0), 872.3 (0), 905.4 (0), 912.3 (0), 914.4 (0),
1046.5 (0), 1060.5 (0), 1076.5 (0), 1093.5 (0), 1118.5 (0), 1121.5 (0),
1169.7 (0), 1254.6 (0), 1270.5 (0), 1308.6 (0), 1320.6 (0), 1323.6 (0),
1513.6 (0), 1533.8 (0), 1570.9 (0), 1587.8 (0), 1766.8 (0), 2187 (0),
2202.9 (0) }
Spot: 2D-001VJW (nucleoli_hela_2d_human)
pI: 5.27 Mw: 57216
%vol: 0.412628 %od: 0.64234
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 870.4 (0), 872.3 (0), 905.4 (0), 912.3 (0), 914.4 (0),
1046.5 (0), 1060.5 (0), 1076.5 (0), 1093.5 (0), 1118.5 (0), 1121.5 (0),
1169.7 (0), 1254.6 (0), 1270.5 (0), 1308.6 (0), 1320.6 (0), 1323.6 (0),
1513.6 (0), 1533.8 (0), 1570.9 (0), 1587.8 (0), 1766.8 (0), 2187 (0),
2202.9 (0) }
[Click to access protein entry]
Spot: 2D-001W96 (nucleoli_hela_2d_human)
pI: 6.26 Mw: 13402
%vol: 0.088998 %od: 0.289759
================
*S10AB_HUMAN*
accession n°: P31949
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1019.5 (0), 1060.4 (0), 1141.6 (0), 1307.7 (0), 1479.7 (0),
1865.9 (0), 2308.2 (0), 3572.7 (0) }
Spot: 2D-001W96 (nucleoli_hela_2d_human)
pI: 6.26 Mw: 13402
%vol: 0.088998 %od: 0.289759
================
*S10AB_HUMAN*
accession n°: P31949
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1019.5 (0), 1060.4 (0), 1141.6 (0), 1307.7 (0), 1479.7 (0),
1865.9 (0), 2308.2 (0), 3572.7 (0) }
[Click to access protein entry]
Spot: 2D-001VI9 (nucleoli_hela_2d_human)
pI: 5.50 Mw: 63566
%vol: 0.124598 %od: 0.123783
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 871.5 (0), 997.4 (0), 1013.4 (0), 1014.4 (0), 1053.7 (0),
1098.5 (0), 1122.5 (0), 1169.5 (0), 1194.7 (0), 1259.6 (0), 1340.8 (0),
1365.7 (0), 1519 (0), 1549.7 (0), 1579.7 (0), 1595.7 (0), 1735.8 (0),
1751.8 (0), 1780.8 (0), 1843.1 (0), 2121.1 (0), 2589.5 (0)
}
Spot: 2D-001VI9 (nucleoli_hela_2d_human)
pI: 5.50 Mw: 63566
%vol: 0.124598 %od: 0.123783
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 871.5 (0), 997.4 (0), 1013.4 (0), 1014.4 (0), 1053.7 (0),
1098.5 (0), 1122.5 (0), 1169.5 (0), 1194.7 (0), 1259.6 (0), 1340.8 (0),
1365.7 (0), 1519 (0), 1549.7 (0), 1579.7 (0), 1595.7 (0), 1735.8 (0),
1751.8 (0), 1780.8 (0), 1843.1 (0), 2121.1 (0), 2589.5 (0)
}
[Click to access protein entry]
Spot: 2D-001VK9 (nucleoli_hela_2d_human)
pI: 4.92 Mw: 56151
%vol: 0.391592 %od: 0.308482
================
*K2C1_HUMAN*
accession n°: P04264
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1006.2 (0), 1143.3 (0), 1179.4 (0), 1265.5 (0), 1277.5 (0),
1383.6 (0), 1475.6 (0), 1479.6 (0), 1638.8 (0), 1716.7 (0), 1967.9 (0),
2124 (0) }
Spot: 2D-001VK9 (nucleoli_hela_2d_human)
pI: 4.92 Mw: 56151
%vol: 0.391592 %od: 0.308482
================
*K2C1_HUMAN*
accession n°: P04264
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1006.2 (0), 1143.3 (0), 1179.4 (0), 1265.5 (0), 1277.5 (0),
1383.6 (0), 1475.6 (0), 1479.6 (0), 1638.8 (0), 1716.7 (0), 1967.9 (0),
2124 (0) }
[Click to access protein entry]
Spot: 2D-001VX3 (nucleoli_hela_2d_human)
pI: 6.01 Mw: 28212
%vol: 0.398065 %od: 0.581973
================
*RPAB1_HUMAN*
accession n°: P19388
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1025.6 (0), 1036.4 (0), 1059.6 (0), 1099.6 (0), 1189.6 (0),
1444.7 (0), 1458.8 (0), 2028 (0) }
Spot: 2D-001VX3 (nucleoli_hela_2d_human)
pI: 6.01 Mw: 28212
%vol: 0.398065 %od: 0.581973
================
*RPAB1_HUMAN*
accession n°: P19388
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1025.6 (0), 1036.4 (0), 1059.6 (0), 1099.6 (0), 1189.6 (0),
1444.7 (0), 1458.8 (0), 2028 (0) }
[Click to access protein entry]
Spot: 2D-001VG3 (nucleoli_hela_2d_human)
pI: 6.76 Mw: 75283
%vol: 0.163433 %od: 0.140855
================
*LMNA_HUMAN*
accession n°: P02545
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 919.3 (0), 1028.5 (0), 1089.5 (0), 1104.5 (0), 1171.6 (0),
1187.5 (0), 1243.6 (0), 1358.7 (0), 1381.6 (0), 1417.7 (0), 1447.7 (0),
1491.7 (0), 1502.7 (0), 1507.7 (0), 1566.7 (0), 1605.8 (0), 1619.8 (0),
1629.8 (0), 1635.8 (0), 1665.8 (0), 1699.9 (0), 1752.8 (0), 1761.9 (0),
1961.9 (0), 1972.9 (0), 2324.1 (0), 2365.1 (0) }
Spot: 2D-001VG3 (nucleoli_hela_2d_human)
pI: 6.76 Mw: 75283
%vol: 0.163433 %od: 0.140855
================
*LMNA_HUMAN*
accession n°: P02545
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 919.3 (0), 1028.5 (0), 1089.5 (0), 1104.5 (0), 1171.6 (0),
1187.5 (0), 1243.6 (0), 1358.7 (0), 1381.6 (0), 1417.7 (0), 1447.7 (0),
1491.7 (0), 1502.7 (0), 1507.7 (0), 1566.7 (0), 1605.8 (0), 1619.8 (0),
1629.8 (0), 1635.8 (0), 1665.8 (0), 1699.9 (0), 1752.8 (0), 1761.9 (0),
1961.9 (0), 1972.9 (0), 2324.1 (0), 2365.1 (0) }
[Click to access protein entry]
Spot: 2D-001VIT (nucleoli_hela_2d_human)
pI: 5.50 Mw: 60991
%vol: 0.195796 %od: 0.136661
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 961.5 (0), 1006.5 (0), 1215.7 (0), 1389.8 (0), 1520.8 (0),
1573 (0), 1601.8 (0), 1627.9 (0), 1684.9 (0), 1771.9 (0), 1919.1 (0),
1939 (0), 2038.1 (0), 2047.3 (0), 2145.2 (0), 2365.5 (0), 2560.4 (0),
3113.8 (0) }
Spot: 2D-001VIT (nucleoli_hela_2d_human)
pI: 5.50 Mw: 60991
%vol: 0.195796 %od: 0.136661
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 961.5 (0), 1006.5 (0), 1215.7 (0), 1389.8 (0), 1520.8 (0),
1573 (0), 1601.8 (0), 1627.9 (0), 1684.9 (0), 1771.9 (0), 1919.1 (0),
1939 (0), 2038.1 (0), 2047.3 (0), 2145.2 (0), 2365.5 (0), 2560.4 (0),
3113.8 (0) }
[Click to access protein entry]
Spot: 2D-001VZP (nucleoli_hela_2d_human)
pI: 5.70 Mw: 24026
%vol: 0.0647261 %od: 0.0938325
================
*PRDX2_HUMAN*
accession n°: P32119
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)QITVNDLPVGR(S) }
peptide masses: { (TRYPSIN)
$m/Z= 924.5 (0), 972.6 (0), 1023.5 (0), 1179.7 (0), 1211.7 (0),
1287.8 (0), 1735.08 (0), 1863.2 (0) }
Spot: 2D-001VZP (nucleoli_hela_2d_human)
pI: 5.70 Mw: 24026
%vol: 0.0647261 %od: 0.0938325
================
*PRDX2_HUMAN*
accession n°: P32119
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)QITVNDLPVGR(S) }
peptide masses: { (TRYPSIN)
$m/Z= 924.5 (0), 972.6 (0), 1023.5 (0), 1179.7 (0), 1211.7 (0),
1287.8 (0), 1735.08 (0), 1863.2 (0) }
[Click to access protein entry]
Spot: 2D-001VL8 (nucleoli_hela_2d_human)
pI: 6.19 Mw: 52478
%vol: 0.271849 %od: 0.233925
================
*K1C10_HUMAN*
accession n°: P13645
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1234.4 (0), 1316.4 (0), 1357.5 (0), 1365.4 (0), 1390.5 (0),
1434.6 (0), 1493.6 (0), 1707.6 (0), 1796.9 (0), 1953 (0), 2112 (0),
2367.3 (0), 2872.5 (0), 2888.6 (0), 2904.6 (0), 3052.9 (0)
}
Spot: 2D-001VL8 (nucleoli_hela_2d_human)
pI: 6.19 Mw: 52478
%vol: 0.271849 %od: 0.233925
================
*K1C10_HUMAN*
accession n°: P13645
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1234.4 (0), 1316.4 (0), 1357.5 (0), 1365.4 (0), 1390.5 (0),
1434.6 (0), 1493.6 (0), 1707.6 (0), 1796.9 (0), 1953 (0), 2112 (0),
2367.3 (0), 2872.5 (0), 2888.6 (0), 2904.6 (0), 3052.9 (0)
}
[Click to access protein entry]
Spot: 2D-001VI0 (nucleoli_hela_2d_human)
pI: 6.34 Mw: 64287
%vol: 0.126215 %od: 0.232018
================
*GSCR2_HUMAN*
accession n°: Q9NZM5
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001VI0 (nucleoli_hela_2d_human)
pI: 6.34 Mw: 64287
%vol: 0.126215 %od: 0.232018
================
*GSCR2_HUMAN*
accession n°: Q9NZM5
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VW1 (nucleoli_hela_2d_human)
pI: 5.50 Mw: 29411
%vol: 0.145633 %od: 0.141448
================
*SPF27_HUMAN*
accession n°: O75934
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 965.4 (0), 1176.5 (0), 1209.6 (0), 1288.7 (0), 1332.7 (0),
1337.7 (0), 1423.7 (0), 1444.7 (0), 1469.8 (0), 1590.9 (0), 1693.8 (0),
1824.9 (0), 1840.9 (0), 2370.1 (0), 2386.1 (0), 2730.3 (0)
}
Spot: 2D-001VW1 (nucleoli_hela_2d_human)
pI: 5.50 Mw: 29411
%vol: 0.145633 %od: 0.141448
================
*SPF27_HUMAN*
accession n°: O75934
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 965.4 (0), 1176.5 (0), 1209.6 (0), 1288.7 (0), 1332.7 (0),
1337.7 (0), 1423.7 (0), 1444.7 (0), 1469.8 (0), 1590.9 (0), 1693.8 (0),
1824.9 (0), 1840.9 (0), 2370.1 (0), 2386.1 (0), 2730.3 (0)
}
[Click to access protein entry]
Spot: 2D-001VII (nucleoli_hela_2d_human)
pI: 5.43 Mw: 61915
%vol: 0.179615 %od: 0.145515
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 871.4 (0), 998.3 (0), 1013.4 (0), 1014.4 (0), 1053.6 (0),
1098.4 (0), 1105.5 (0), 1122.5 (0), 1169.5 (0), 1194.7 (0), 1259.5 (0),
1340.8 (0), 1365.6 (0), 1518.9 (0), 1549.6 (0), 1595.7 (0), 1724.9 (0),
1751.7 (0), 1753.7 (0), 1780.7 (0), 1843 (0), 1917 (0), 2589.3 (0)
}
Spot: 2D-001VII (nucleoli_hela_2d_human)
pI: 5.43 Mw: 61915
%vol: 0.179615 %od: 0.145515
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 871.4 (0), 998.3 (0), 1013.4 (0), 1014.4 (0), 1053.6 (0),
1098.4 (0), 1105.5 (0), 1122.5 (0), 1169.5 (0), 1194.7 (0), 1259.5 (0),
1340.8 (0), 1365.6 (0), 1518.9 (0), 1549.6 (0), 1595.7 (0), 1724.9 (0),
1751.7 (0), 1753.7 (0), 1780.7 (0), 1843 (0), 1917 (0), 2589.3 (0)
}
[Click to access protein entry]
Spot: 2D-001VJN (nucleoli_hela_2d_human)
pI: 6.00 Mw: 57865
%vol: 0.126215 %od: 0.175761
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(K)YGVSGYPTLK(I);; $m/Z=(K)FIQENIFGICPHMTEDNK(D);; $m/Z=(-)SDVLELTDDNFESR(I) }
peptide masses: { (TRYPSIN)
$m/Z= 1084.6 (0), 1172.6 (0), 1179.7 (0), 1191.7 (0), 1236.6 (0),
1359.7 (0), 1370.8 (0), 1515.8 (0), 1579.9 (0), 1619.9 (0), 1780.9 (0),
1833 (0), 2349.2 (0) }
================
*PKNX1_HUMAN*
accession n: P55347
Identification Methods:
* MAPPING: {MS/MS}
Spot: 2D-001VJN (nucleoli_hela_2d_human)
pI: 6.00 Mw: 57865
%vol: 0.126215 %od: 0.175761
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(K)YGVSGYPTLK(I);; $m/Z=(K)FIQENIFGICPHMTEDNK(D);; $m/Z=(-)SDVLELTDDNFESR(I) }
peptide masses: { (TRYPSIN)
$m/Z= 1084.6 (0), 1172.6 (0), 1179.7 (0), 1191.7 (0), 1236.6 (0),
1359.7 (0), 1370.8 (0), 1515.8 (0), 1579.9 (0), 1619.9 (0), 1780.9 (0),
1833 (0), 2349.2 (0) }
================
*PKNX1_HUMAN*
accession n: P55347
Identification Methods:
* MAPPING: {MS/MS}
[Click to access protein entry]
Spot: 2D-001VIK (nucleoli_hela_2d_human)
pI: 5.56 Mw: 61915
%vol: 0.221686 %od: 0.161104
================
*TSYL1_HUMAN*
accession n°: Q9H0U9
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 873.4 (0), 935.4 (0), 1000.5 (0), 1017.5 (0), 1070.5 (0),
1134.6 (0), 1182.6 (0), 1226.6 (0), 1270.7 (0), 1559.8 (0), 1661.8 (0),
1971 (0), 1987 (0), 2082.1 (0), 2242.1 (0), 2258.1 (0), 2325.1 (0),
2341.1 (0), 2963.5 (0) }
Spot: 2D-001VIK (nucleoli_hela_2d_human)
pI: 5.56 Mw: 61915
%vol: 0.221686 %od: 0.161104
================
*TSYL1_HUMAN*
accession n°: Q9H0U9
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 873.4 (0), 935.4 (0), 1000.5 (0), 1017.5 (0), 1070.5 (0),
1134.6 (0), 1182.6 (0), 1226.6 (0), 1270.7 (0), 1559.8 (0), 1661.8 (0),
1971 (0), 1987 (0), 2082.1 (0), 2242.1 (0), 2258.1 (0), 2325.1 (0),
2341.1 (0), 2963.5 (0) }
[Click to access protein entry]
Spot: 2D-001VIU (nucleoli_hela_2d_human)
pI: 5.67 Mw: 61221
%vol: 0.186087 %od: 0.103788
================
*TCPE_HUMAN*
accession n°: P48643
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.3 (0), 1115.4 (0), 1183.4 (0), 1265.5 (0), 1290.4 (0),
1610.5 (0), 1667.6 (0), 1713.5 (0), 1738.6 (0), 3112.9 (0)
}
Spot: 2D-001VIU (nucleoli_hela_2d_human)
pI: 5.67 Mw: 61221
%vol: 0.186087 %od: 0.103788
================
*TCPE_HUMAN*
accession n°: P48643
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1093.3 (0), 1115.4 (0), 1183.4 (0), 1265.5 (0), 1290.4 (0),
1610.5 (0), 1667.6 (0), 1713.5 (0), 1738.6 (0), 3112.9 (0)
}
[Click to access protein entry]
Spot: 2D-001VKH (nucleoli_hela_2d_human)
pI: 6.56 Mw: 55522
%vol: 0.153724 %od: 0.219225
================
*TCPB_HUMAN*
accession n°: P78371
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1130.6 (0), 1275.7 (0), 1330.7 (0), 1376.8 (0), 1484.9 (0),
1518 (0), 1583 (0), 1799 (0), 1913.1 (0), 1960.1 (0), 2041.1 (0),
2097.2 (0), 2181.2 (0), 2265.4 (0), 2288.3 (0), 2363.3 (0), 2544.4 (0),
2687.6 (0) }
Spot: 2D-001VKH (nucleoli_hela_2d_human)
pI: 6.56 Mw: 55522
%vol: 0.153724 %od: 0.219225
================
*TCPB_HUMAN*
accession n°: P78371
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1130.6 (0), 1275.7 (0), 1330.7 (0), 1376.8 (0), 1484.9 (0),
1518 (0), 1583 (0), 1799 (0), 1913.1 (0), 1960.1 (0), 2041.1 (0),
2097.2 (0), 2181.2 (0), 2265.4 (0), 2288.3 (0), 2363.3 (0), 2544.4 (0),
2687.6 (0) }
[Click to access protein entry]
Spot: 2D-001VI5 (nucleoli_hela_2d_human)
pI: 6.68 Mw: 64287
%vol: 0.294503 %od: 0.235068
================
*LMNA_HUMAN*
accession n°: P02545
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 919.4 (0), 1028.6 (0), 1089.6 (0), 1165.5 (0), 1171.7 (0),
1187.6 (0), 1243.7 (0), 1275.7 (0), 1304.6 (0), 1358.8 (0), 1359.7 (0),
1381.7 (0), 1417.8 (0), 1507.8 (0), 1605.9 (0), 1619.9 (0), 1629.9 (0),
1635.9 (0), 1649.8 (0), 1676.9 (0), 1688 (0), 1700.1 (0), 1730 (0),
1753 (0), 1962.1 (0), 2324.3 (0) }
Spot: 2D-001VI5 (nucleoli_hela_2d_human)
pI: 6.68 Mw: 64287
%vol: 0.294503 %od: 0.235068
================
*LMNA_HUMAN*
accession n°: P02545
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 919.4 (0), 1028.6 (0), 1089.6 (0), 1165.5 (0), 1171.7 (0),
1187.6 (0), 1243.7 (0), 1275.7 (0), 1304.6 (0), 1358.8 (0), 1359.7 (0),
1381.7 (0), 1417.8 (0), 1507.8 (0), 1605.9 (0), 1619.9 (0), 1629.9 (0),
1635.9 (0), 1649.8 (0), 1676.9 (0), 1688 (0), 1700.1 (0), 1730 (0),
1753 (0), 1962.1 (0), 2324.3 (0) }
[Click to access protein entry]
Spot: 2D-001VKX (nucleoli_hela_2d_human)
pI: 6.74 Mw: 53474
%vol: 0.205505 %od: 0.163942
================
*RUVB1_HUMAN*
accession n°: Q9Y265
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1230.7 (0), 1273.6 (0), 1300.7 (0), 1310.7 (0), 1368.7 (0),
1530.9 (0), 1561.8 (0), 1687.9 (0), 1891 (0), 1949 (0), 2020 (0),
2324.2 (0), 2341.2 (0), 2387.3 (0), 2512.3 (0), 2577.4 (0), 2593.3 (0),
2795.4 (0), 2926.3 (0) }
Spot: 2D-001VKX (nucleoli_hela_2d_human)
pI: 6.74 Mw: 53474
%vol: 0.205505 %od: 0.163942
================
*RUVB1_HUMAN*
accession n°: Q9Y265
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1230.7 (0), 1273.6 (0), 1300.7 (0), 1310.7 (0), 1368.7 (0),
1530.9 (0), 1561.8 (0), 1687.9 (0), 1891 (0), 1949 (0), 2020 (0),
2324.2 (0), 2341.2 (0), 2387.3 (0), 2512.3 (0), 2577.4 (0), 2593.3 (0),
2795.4 (0), 2926.3 (0) }
[Click to access protein entry]
Spot: 2D-001VHW (nucleoli_hela_2d_human)
pI: 6.47 Mw: 64772
%vol: 0.114888 %od: 0.118826
================
*GNL3_HUMAN*
accession n°: Q9BVP2
Identification Methods:
* MAPPING: {PMF,MS/MS}
================
*GSCR2_HUMAN*
accession n: Q9NZM5
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001VHW (nucleoli_hela_2d_human)
pI: 6.47 Mw: 64772
%vol: 0.114888 %od: 0.118826
================
*GNL3_HUMAN*
accession n°: Q9BVP2
Identification Methods:
* MAPPING: {PMF,MS/MS}
================
*GSCR2_HUMAN*
accession n: Q9NZM5
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VKW (nucleoli_hela_2d_human)
pI: 5.86 Mw: 53474
%vol: 0.360847 %od: 0.367155
================
*K2C8_HUMAN*
accession n°: P05787
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)ASLEAAIADAEQR(G);; $m/Z=(R)SLDMoxDSIIAEVK(A);; $m/Z=(R)LEGLTDEINFLR(Q) }
peptide masses: { (TRYPSIN)
$m/Z= 1277.5 (0), 1320.4 (0), 1336.4 (0), 1344.4 (0), 1368.5 (0),
1419.6 (0), 1428.5 (0), 1813.7 (0), 1863.7 (0), 1879.7 (0), 2034 (0),
2050 (0), 2125 (0) }
Spot: 2D-001VKW (nucleoli_hela_2d_human)
pI: 5.86 Mw: 53474
%vol: 0.360847 %od: 0.367155
================
*K2C8_HUMAN*
accession n°: P05787
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)ASLEAAIADAEQR(G);; $m/Z=(R)SLDMoxDSIIAEVK(A);; $m/Z=(R)LEGLTDEINFLR(Q) }
peptide masses: { (TRYPSIN)
$m/Z= 1277.5 (0), 1320.4 (0), 1336.4 (0), 1344.4 (0), 1368.5 (0),
1419.6 (0), 1428.5 (0), 1813.7 (0), 1863.7 (0), 1879.7 (0), 2034 (0),
2050 (0), 2125 (0) }
[Click to access protein entry]
Spot: 2D-001VH5 (nucleoli_hela_2d_human)
pI: 5.65 Mw: 68886
%vol: 0.249195 %od: 0.158901
================
*HSP71_HUMAN*
accession n°: P08107
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1003.7 (0), 1017.7 (0), 1109.7 (0), 1137.7 (0), 1183.8 (0),
1197.9 (0), 1228.8 (0), 1303.8 (0), 1315.8 (0), 1366.8 (0), 1418 (0),
1466 (0), 1487.9 (0), 1542.9 (0), 1659.1 (0), 1676 (0), 1681.1 (0),
1688.1 (0), 2265.4 (0), 2786.7 (0), 3001.8 (0), 3055.8 (0)
}
Spot: 2D-001VH5 (nucleoli_hela_2d_human)
pI: 5.65 Mw: 68886
%vol: 0.249195 %od: 0.158901
================
*HSP71_HUMAN*
accession n°: P08107
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1003.7 (0), 1017.7 (0), 1109.7 (0), 1137.7 (0), 1183.8 (0),
1197.9 (0), 1228.8 (0), 1303.8 (0), 1315.8 (0), 1366.8 (0), 1418 (0),
1466 (0), 1487.9 (0), 1542.9 (0), 1659.1 (0), 1676 (0), 1681.1 (0),
1688.1 (0), 2265.4 (0), 2786.7 (0), 3001.8 (0), 3055.8 (0)
}
[Click to access protein entry]
Spot: 2D-001VND (nucleoli_hela_2d_human)
pI: 5.59 Mw: 45837
%vol: 0.252431 %od: 0.190546
================
*K1C18_HUMAN*
accession n°: P05783
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 965.7 (0), 975.7 (0), 1041.9 (0), 1256 (0), 1268 (0), 1293 (0),
1320 (0), 1396.1 (0), 1420.1 (0), 1523.2 (0), 1884.5 (0)
}
Spot: 2D-001VND (nucleoli_hela_2d_human)
pI: 5.59 Mw: 45837
%vol: 0.252431 %od: 0.190546
================
*K1C18_HUMAN*
accession n°: P05783
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 965.7 (0), 975.7 (0), 1041.9 (0), 1256 (0), 1268 (0), 1293 (0),
1320 (0), 1396.1 (0), 1420.1 (0), 1523.2 (0), 1884.5 (0)
}
[Click to access protein entry]
Spot: 2D-001VIA (nucleoli_hela_2d_human)
pI: 5.52 Mw: 63805
%vol: 0.144015 %od: 0.132721
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 871.4 (0), 1013.4 (0), 1014.3 (0), 1053.6 (0), 1098.4 (0),
1105.5 (0), 1194.6 (0), 1259.5 (0), 1340.7 (0), 1518.9 (0), 1549.6 (0),
1595.7 (0), 1780.7 (0), 1917 (0) }
Spot: 2D-001VIA (nucleoli_hela_2d_human)
pI: 5.52 Mw: 63805
%vol: 0.144015 %od: 0.132721
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 871.4 (0), 1013.4 (0), 1014.3 (0), 1053.6 (0), 1098.4 (0),
1105.5 (0), 1194.6 (0), 1259.5 (0), 1340.7 (0), 1518.9 (0), 1549.6 (0),
1595.7 (0), 1780.7 (0), 1917 (0) }
[Click to access protein entry]
Spot: 2D-001VMG (nucleoli_hela_2d_human)
pI: 5.19 Mw: 48313
%vol: 0.234632 %od: 0.198679
================
*K1C17_HUMAN*
accession n°: Q04695
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)EVATNSELVQSGK(S);; $m/Z=(R)ALEEANTELEVK(I);; $m/Z=(R)LLEGEDAHLTQYK(K);; $m/Z=(R)GQVGGEINVEMoxDAAPGVDLSR(I) }
Spot: 2D-001VMG (nucleoli_hela_2d_human)
pI: 5.19 Mw: 48313
%vol: 0.234632 %od: 0.198679
================
*K1C17_HUMAN*
accession n°: Q04695
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)EVATNSELVQSGK(S);; $m/Z=(R)ALEEANTELEVK(I);; $m/Z=(R)LLEGEDAHLTQYK(K);; $m/Z=(R)GQVGGEINVEMoxDAAPGVDLSR(I) }
[Click to access protein entry]
Spot: 2D-001VR9 (nucleoli_hela_2d_human)
pI: 4.79 Mw: 37314
%vol: 0.412628 %od: 1.05016
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {MS/MS} {PMF}
peptide sequences: {
 $m/Z=(K)MoxSVQPTVSLGGFEITPPVVLR(L) }
peptide masses: { (TRYPSIN)
$m/Z= 974.5 (0), 1023.5 (0), 1568.7 (0), 2227.2 (0), 2243.2 (0),
2945.4 (0) }
Spot: 2D-001VR9 (nucleoli_hela_2d_human)
pI: 4.79 Mw: 37314
%vol: 0.412628 %od: 1.05016
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {MS/MS} {PMF}
peptide sequences: {
 $m/Z=(K)MoxSVQPTVSLGGFEITPPVVLR(L) }
peptide masses: { (TRYPSIN)
$m/Z= 974.5 (0), 1023.5 (0), 1568.7 (0), 2227.2 (0), 2243.2 (0),
2945.4 (0) }
[Click to access protein entry]
Spot: 2D-001VOK (nucleoli_hela_2d_human)
pI: 5.50 Mw: 42256
%vol: 0.409392 %od: 0.517667
================
*RPAC1_HUMAN*
accession n°: O15160
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 974.6 (0), 1098.6 (0), 1201.7 (0), 1413.8 (0), 1429.7 (0),
1467.7 (0), 1851.8 (0), 2084.1 (0), 2294.2 (0), 2870.6 (0)
}
Spot: 2D-001VOK (nucleoli_hela_2d_human)
pI: 5.50 Mw: 42256
%vol: 0.409392 %od: 0.517667
================
*RPAC1_HUMAN*
accession n°: O15160
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 974.6 (0), 1098.6 (0), 1201.7 (0), 1413.8 (0), 1429.7 (0),
1467.7 (0), 1851.8 (0), 2084.1 (0), 2294.2 (0), 2870.6 (0)
}
[Click to access protein entry]
Spot: 2D-001VKG (nucleoli_hela_2d_human)
pI: 5.63 Mw: 56151
%vol: 0.336575 %od: 0.275694
================
*K2C7_HUMAN*
accession n°: P08729
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)LQAEIDNIK(N);; $m/Z=(K)FETLQAQAGK(H);; $m/Z=(R)GQLEALQVDGGR(L);; $m/Z=(K)LALDIEIATYR(K);; $m/Z=(R)EYQELMoxSVK(L);; $m/Z=(R)AKQEELEAALQR(A);; $m/Z=(R)SLDLDGIIAEVK(A);; $m/Z=(R)TLNETELTELQSQISDTSVVLSMoxDNSR(S);; $m/Z=(K)VDALNDEINFLR(T);; $m/Z=(R)TAAENEFVVLKK(D);; $m/Z=(R)TMQDVVEDFK(N);; $m/Z=(R)SAYGGPVGAGIR(E);; $m/Z=(R)EVTINQSLLAPLR(L);; $m/Z=(R)LDADPSLQR(V) }
peptide masses: { (TRYPSIN)
$m/Z= 1242.4 (0), 1277.5 (0), 1331.5 (0), 1364.5 (0), 1385.5 (0),
1418.5 (0), 1442.6 (0), 1453.6 (0), 1759.8 (0), 1816.7 (0), 3010.5 (0),
3026.6 (0) }
Spot: 2D-001VKG (nucleoli_hela_2d_human)
pI: 5.63 Mw: 56151
%vol: 0.336575 %od: 0.275694
================
*K2C7_HUMAN*
accession n°: P08729
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)LQAEIDNIK(N);; $m/Z=(K)FETLQAQAGK(H);; $m/Z=(R)GQLEALQVDGGR(L);; $m/Z=(K)LALDIEIATYR(K);; $m/Z=(R)EYQELMoxSVK(L);; $m/Z=(R)AKQEELEAALQR(A);; $m/Z=(R)SLDLDGIIAEVK(A);; $m/Z=(R)TLNETELTELQSQISDTSVVLSMoxDNSR(S);; $m/Z=(K)VDALNDEINFLR(T);; $m/Z=(R)TAAENEFVVLKK(D);; $m/Z=(R)TMQDVVEDFK(N);; $m/Z=(R)SAYGGPVGAGIR(E);; $m/Z=(R)EVTINQSLLAPLR(L);; $m/Z=(R)LDADPSLQR(V) }
peptide masses: { (TRYPSIN)
$m/Z= 1242.4 (0), 1277.5 (0), 1331.5 (0), 1364.5 (0), 1385.5 (0),
1418.5 (0), 1442.6 (0), 1453.6 (0), 1759.8 (0), 1816.7 (0), 3010.5 (0),
3026.6 (0) }
[Click to access protein entry]
Spot: 2D-001W5I (nucleoli_hela_2d_human)
pI: 5.65 Mw: 17077
%vol: 0.195796 %od: 0.444084
================
*RPAC2_HUMAN*
accession n°: Q9Y2S0
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 896.4 (0), 1214.7 (0), 1362.7 (0), 1378.7 (0), 1490.8 (0),
1506.8 (0), 2082.9 (0), 2264.1 (0) }
Spot: 2D-001W5I (nucleoli_hela_2d_human)
pI: 5.65 Mw: 17077
%vol: 0.195796 %od: 0.444084
================
*RPAC2_HUMAN*
accession n°: Q9Y2S0
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 896.4 (0), 1214.7 (0), 1362.7 (0), 1378.7 (0), 1490.8 (0),
1506.8 (0), 2082.9 (0), 2264.1 (0) }
[Click to access protein entry]
Spot: 2D-001VIB (nucleoli_hela_2d_human)
pI: 5.61 Mw: 63805
%vol: 0.364084 %od: 0.334578
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)GSYGDLGGPIITTQVTIPK(D);; $m/Z=(R)NLPLPPPPPPR(G);; $m/Z=(R)AQPYDPNFYDETYDYGGFTMoxMoxFDDRR(G);; $m/Z=(R)IITITGTQDQIQNAQYLLQNSVK(Q);; $m/Z=(R)LLIHQSLAGGIIGVK(G);; $m/Z=(R)ILSISADIETIGEILK(K);; $m/Z=(K)IILDLISESPIK(G);; $m/Z=(K)IDEPLEGSEDR(I) }
Spot: 2D-001VIB (nucleoli_hela_2d_human)
pI: 5.61 Mw: 63805
%vol: 0.364084 %od: 0.334578
================
*HNRPK_HUMAN*
accession n°: P61978
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)GSYGDLGGPIITTQVTIPK(D);; $m/Z=(R)NLPLPPPPPPR(G);; $m/Z=(R)AQPYDPNFYDETYDYGGFTMoxMoxFDDRR(G);; $m/Z=(R)IITITGTQDQIQNAQYLLQNSVK(Q);; $m/Z=(R)LLIHQSLAGGIIGVK(G);; $m/Z=(R)ILSISADIETIGEILK(K);; $m/Z=(K)IILDLISESPIK(G);; $m/Z=(K)IDEPLEGSEDR(I) }
[Click to access protein entry]
Spot: 2D-001W30 (nucleoli_hela_2d_human)
pI: 5.58 Mw: 19433
%vol: 0.0598715 %od: 0.142253
================
*ZN593_HUMAN*
accession n°: O00488
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001W30 (nucleoli_hela_2d_human)
pI: 5.58 Mw: 19433
%vol: 0.0598715 %od: 0.142253
================
*ZN593_HUMAN*
accession n°: O00488
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VPE (nucleoli_hela_2d_human)
pI: 4.79 Mw: 38894
%vol: 0.412628 %od: 2.47994
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 910.5 (0), 931.5 (0), 974.5 (0), 1023.5 (0), 1568.5 (0),
2160 (0), 2227.2 (0), 2243.2 (0) }
Spot: 2D-001VPE (nucleoli_hela_2d_human)
pI: 4.79 Mw: 38894
%vol: 0.412628 %od: 2.47994
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 910.5 (0), 931.5 (0), 974.5 (0), 1023.5 (0), 1568.5 (0),
2160 (0), 2227.2 (0), 2243.2 (0) }
[Click to access protein entry]
Spot: 2D-001VQC (nucleoli_hela_2d_human)
pI: 4.68 Mw: 38388
%vol: 0.368938 %od: 0.494283
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 910.5 (0), 931.5 (0), 974.6 (0), 1023.6 (0), 1360.8 (0),
1568.9 (0), 2145.2 (0), 2161.2 (0), 2222.4 (0), 2243.4 (0), 2945.8 (0)
}
Spot: 2D-001VQC (nucleoli_hela_2d_human)
pI: 4.68 Mw: 38388
%vol: 0.368938 %od: 0.494283
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 910.5 (0), 931.5 (0), 974.6 (0), 1023.6 (0), 1360.8 (0),
1568.9 (0), 2145.2 (0), 2161.2 (0), 2222.4 (0), 2243.4 (0), 2945.8 (0)
}
[Click to access protein entry]
Spot: 2D-001VZL (nucleoli_hela_2d_human)
pI: 6.45 Mw: 23931
%vol: 0.0582532 %od: 0.207067
================
*NOP16_HUMAN*
accession n°: Q9Y3C1
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001VZL (nucleoli_hela_2d_human)
pI: 6.45 Mw: 23931
%vol: 0.0582532 %od: 0.207067
================
*NOP16_HUMAN*
accession n°: Q9Y3C1
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VNR (nucleoli_hela_2d_human)
pI: 5.47 Mw: 44313
%vol: 0.338193 %od: 0.276456
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 976.5 (0), 1132.6 (0), 1198.8 (0), 1516.8 (0), 1791 (0),
1954.2 (0), 2231.2 (0), 2367.4 (0) }
Spot: 2D-001VNR (nucleoli_hela_2d_human)
pI: 5.47 Mw: 44313
%vol: 0.338193 %od: 0.276456
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 976.5 (0), 1132.6 (0), 1198.8 (0), 1516.8 (0), 1791 (0),
1954.2 (0), 2231.2 (0), 2367.4 (0) }
[Click to access protein entry]
Spot: 2D-001W9G (nucleoli_hela_2d_human)
pI: 5.72 Mw: 14400
%vol: 0.187705 %od: 0.775993
================
*S10A4_HUMAN*
accession n°: P26447
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(K)LMoxSNLDSNR(D);; $m/Z=(K)ALDVMoxVSTFHK(Y);; $m/Z=(R)ELPSFLGK(R) }
peptide masses: { (TRYPSIN)
$m/Z= 890.7 (0), 909.6 (0), 1065.7 (0), 1247.9 (0), 1263.9 (0)
}
Spot: 2D-001W9G (nucleoli_hela_2d_human)
pI: 5.72 Mw: 14400
%vol: 0.187705 %od: 0.775993
================
*S10A4_HUMAN*
accession n°: P26447
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(K)LMoxSNLDSNR(D);; $m/Z=(K)ALDVMoxVSTFHK(Y);; $m/Z=(R)ELPSFLGK(R) }
peptide masses: { (TRYPSIN)
$m/Z= 890.7 (0), 909.6 (0), 1065.7 (0), 1247.9 (0), 1263.9 (0)
}
[Click to access protein entry]
Spot: 2D-001VGX (nucleoli_hela_2d_human)
pI: 5.50 Mw: 70432
%vol: 0.375411 %od: 0.263832
================
*HSP7C_HUMAN*
accession n°: P11142
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)GTLDPVEK(A);; $m/Z=(K)NSLESYAFNMoxK(A);; $m/Z=(K)GPAVGIDLGTTYSCVGVFQHGK(V);; $m/Z=(K)VEIIANDQGNR(T);; $m/Z=(R)TTPSYVAFTDTER(L);; $m/Z=(R)RFDDAVVQSDMoxK(H);; $m/Z=(K)SFYPEEVSSMoxVLTK(M);; $m/Z=(K)TVTNAVVTVPAYFNDSQR(Q);; $m/Z=(K)DAGTIAGLNVLR(I);; $m/Z=(R)IINEPTAAAIAYGLDKK(V) }
peptide masses: { (TRYPSIN)
$m/Z= 1081.7 (0), 1197.8 (0), 1199.8 (0), 1228.8 (0), 1251.8 (0),
1253.8 (0), 1426.8 (0), 1480.9 (0), 1487.9 (0), 1632.9 (0), 1666 (0),
1691.9 (0), 1746 (0), 1788.1 (0), 1982.2 (0), 2263.4 (0), 2697.6 (0),
2774.6 (0) }
Spot: 2D-001VGX (nucleoli_hela_2d_human)
pI: 5.50 Mw: 70432
%vol: 0.375411 %od: 0.263832
================
*HSP7C_HUMAN*
accession n°: P11142
Identification Methods:
* MAPPING: {PMF,MS/MS}
peptide sequences: {
 $m/Z=(R)GTLDPVEK(A);; $m/Z=(K)NSLESYAFNMoxK(A);; $m/Z=(K)GPAVGIDLGTTYSCVGVFQHGK(V);; $m/Z=(K)VEIIANDQGNR(T);; $m/Z=(R)TTPSYVAFTDTER(L);; $m/Z=(R)RFDDAVVQSDMoxK(H);; $m/Z=(K)SFYPEEVSSMoxVLTK(M);; $m/Z=(K)TVTNAVVTVPAYFNDSQR(Q);; $m/Z=(K)DAGTIAGLNVLR(I);; $m/Z=(R)IINEPTAAAIAYGLDKK(V) }
peptide masses: { (TRYPSIN)
$m/Z= 1081.7 (0), 1197.8 (0), 1199.8 (0), 1228.8 (0), 1251.8 (0),
1253.8 (0), 1426.8 (0), 1480.9 (0), 1487.9 (0), 1632.9 (0), 1666 (0),
1691.9 (0), 1746 (0), 1788.1 (0), 1982.2 (0), 2263.4 (0), 2697.6 (0),
2774.6 (0) }
[Click to access protein entry]
Spot: 2D-001VJV (nucleoli_hela_2d_human)
pI: 5.21 Mw: 57216
%vol: 0.254049 %od: 0.189614
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1060.5 (0), 1093.5 (0), 1115.5 (0), 1125.6 (0), 1169.7 (0),
1254.5 (0), 1270.5 (0), 1311.6 (0), 1323.6 (0), 1428.7 (0), 1495.7 (0),
1510.7 (0), 1533.8 (0), 1570.9 (0), 1587.8 (0), 1668.8 (0), 1766.8 (0),
2126.1 (0), 2187 (0), 2202.9 (0) }
Spot: 2D-001VJV (nucleoli_hela_2d_human)
pI: 5.21 Mw: 57216
%vol: 0.254049 %od: 0.189614
================
*VIME_HUMAN*
accession n°: P08670
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1060.5 (0), 1093.5 (0), 1115.5 (0), 1125.6 (0), 1169.7 (0),
1254.5 (0), 1270.5 (0), 1311.6 (0), 1323.6 (0), 1428.7 (0), 1495.7 (0),
1510.7 (0), 1533.8 (0), 1570.9 (0), 1587.8 (0), 1668.8 (0), 1766.8 (0),
2126.1 (0), 2187 (0), 2202.9 (0) }
[Click to access protein entry]
Spot: 2D-001VTA (nucleoli_hela_2d_human)
pI: 5.94 Mw: 33604
%vol: 0.147252 %od: 0.173812
================
*IF6_HUMAN*
accession n°: P56537
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)HGLLVPNNTTDQELQHIR(N) }
Spot: 2D-001VTA (nucleoli_hela_2d_human)
pI: 5.94 Mw: 33604
%vol: 0.147252 %od: 0.173812
================
*IF6_HUMAN*
accession n°: P56537
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(R)HGLLVPNNTTDQELQHIR(N) }
[Click to access protein entry]
Spot: 2D-001VMW (nucleoli_hela_2d_human)
pI: 6.43 Mw: 47236
%vol: 0.268613 %od: 0.230833
================
*PA2G4_HUMAN*
accession n°: Q9UQ80
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1182.4 (0), 1253.4 (0), 1285.5 (0), 1366.5 (0), 1375.6 (0),
1629.7 (0), 2185.1 (0), 2264.1 (0), 2348.2 (0), 2476.3 (0), 2541.3 (0),
3236 (0) }
Spot: 2D-001VMW (nucleoli_hela_2d_human)
pI: 6.43 Mw: 47236
%vol: 0.268613 %od: 0.230833
================
*PA2G4_HUMAN*
accession n°: Q9UQ80
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1182.4 (0), 1253.4 (0), 1285.5 (0), 1366.5 (0), 1375.6 (0),
1629.7 (0), 2185.1 (0), 2264.1 (0), 2348.2 (0), 2476.3 (0), 2541.3 (0),
3236 (0) }
[Click to access protein entry]
Spot: 2D-001VKI (nucleoli_hela_2d_human)
pI: 6.67 Mw: 55941
%vol: 0.360847 %od: 0.295901
================
*PRP19_HUMAN*
accession n°: Q9UMS4
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1374.8 (0), 1798.8 (0), 1917 (0), 2093.3 (0), 2473.3 (0),
2601.4 (0), 2930.8 (0) }
Spot: 2D-001VKI (nucleoli_hela_2d_human)
pI: 6.67 Mw: 55941
%vol: 0.360847 %od: 0.295901
================
*PRP19_HUMAN*
accession n°: Q9UMS4
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1374.8 (0), 1798.8 (0), 1917 (0), 2093.3 (0), 2473.3 (0),
2601.4 (0), 2930.8 (0) }
[Click to access protein entry]
Spot: 2D-001VVY (nucleoli_hela_2d_human)
pI: 6.55 Mw: 29587
%vol: 0.241104 %od: 0.297891
================
*EXOS4_HUMAN*
accession n°: Q9NPD3
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 968.4 (0), 999.4 (0), 1048.4 (0), 1109.4 (0), 1237.5 (0),
1324.6 (0), 1624.8 (0), 1986.9 (0), 2002.9 (0), 2018.9 (0)
}
Spot: 2D-001VVY (nucleoli_hela_2d_human)
pI: 6.55 Mw: 29587
%vol: 0.241104 %od: 0.297891
================
*EXOS4_HUMAN*
accession n°: Q9NPD3
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 968.4 (0), 999.4 (0), 1048.4 (0), 1109.4 (0), 1237.5 (0),
1324.6 (0), 1624.8 (0), 1986.9 (0), 2002.9 (0), 2018.9 (0)
}
[Click to access protein entry]
Spot: 2D-001VGG (nucleoli_hela_2d_human)
pI: 5.69 Mw: 72414
%vol: 0.173142 %od: 0.101627
================
*GRP75_HUMAN*
accession n°: P38646
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1045.5 (0), 1149.5 (0), 1242.7 (0), 1290.6 (0), 1361.7 (0),
1450.7 (0), 1462.7 (0), 1569.8 (0), 1592.9 (0), 1694.8 (0), 1808.8 (0)
}
Spot: 2D-001VGG (nucleoli_hela_2d_human)
pI: 5.69 Mw: 72414
%vol: 0.173142 %od: 0.101627
================
*GRP75_HUMAN*
accession n°: P38646
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1045.5 (0), 1149.5 (0), 1242.7 (0), 1290.6 (0), 1361.7 (0),
1450.7 (0), 1462.7 (0), 1569.8 (0), 1592.9 (0), 1694.8 (0), 1808.8 (0)
}
[Click to access protein entry]
Spot: 2D-001VOQ (nucleoli_hela_2d_human)
pI: 6.59 Mw: 41615
%vol: 0.118125 %od: 0.247692
================
*EBP2_HUMAN*
accession n°: Q99848
Identification Methods:
* MAPPING: {PMF}
================
*RBM4B_HUMAN*
accession n: Q9BQ04
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 929.5 (0), 975.4 (0), 985.4 (0), 1257.6 (0), 1264.6 (0),
1499.7 (0), 1838.9 (0), 1889.9 (0), 2049 (0) }
Spot: 2D-001VOQ (nucleoli_hela_2d_human)
pI: 6.59 Mw: 41615
%vol: 0.118125 %od: 0.247692
================
*EBP2_HUMAN*
accession n°: Q99848
Identification Methods:
* MAPPING: {PMF}
================
*RBM4B_HUMAN*
accession n: Q9BQ04
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 929.5 (0), 975.4 (0), 985.4 (0), 1257.6 (0), 1264.6 (0),
1499.7 (0), 1838.9 (0), 1889.9 (0), 2049 (0) }
[Click to access protein entry]
Spot: 2D-001VZ6 (nucleoli_hela_2d_human)
pI: 5.96 Mw: 24459
%vol: 0.042072 %od: 0.171101
================
*RL9_HUMAN*
accession n°: P32969
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001VZ6 (nucleoli_hela_2d_human)
pI: 5.96 Mw: 24459
%vol: 0.042072 %od: 0.171101
================
*RL9_HUMAN*
accession n°: P32969
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VKA (nucleoli_hela_2d_human)
pI: 4.97 Mw: 56151
%vol: 0.346284 %od: 0.231679
================
*GRWD1_HUMAN*
accession n°: Q9BQ67
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1418.53 (0), 1534.63 (0), 1574.7 (0), 1772.8 (0), 1796.9 (0),
1923 (0), 1939 (0), 2321.1 (0), 2423.2 (0), 2766.5 (0), 2770.4 (0),
2971.4 (0) }
Spot: 2D-001VKA (nucleoli_hela_2d_human)
pI: 4.97 Mw: 56151
%vol: 0.346284 %od: 0.231679
================
*GRWD1_HUMAN*
accession n°: Q9BQ67
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1418.53 (0), 1534.63 (0), 1574.7 (0), 1772.8 (0), 1796.9 (0),
1923 (0), 1939 (0), 2321.1 (0), 2423.2 (0), 2766.5 (0), 2770.4 (0),
2971.4 (0) }
[Click to access protein entry]
Spot: 2D-001VRG (nucleoli_hela_2d_human)
pI: 4.65 Mw: 36910
%vol: 0.41101 %od: 0.649329
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 910.4 (0), 931.4 (0), 974.5 (0), 1023.5 (0), 1360.6 (0),
1568.7 (0), 1835.8 (0), 2144.9 (0), 2160.9 (0), 2227.2 (0), 2243.1 (0),
2929.4 (0), 2945.4 (0) }
Spot: 2D-001VRG (nucleoli_hela_2d_human)
pI: 4.65 Mw: 36910
%vol: 0.41101 %od: 0.649329
================
*NPM_HUMAN*
accession n°: P06748
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 910.4 (0), 931.4 (0), 974.5 (0), 1023.5 (0), 1360.6 (0),
1568.7 (0), 1835.8 (0), 2144.9 (0), 2160.9 (0), 2227.2 (0), 2243.1 (0),
2929.4 (0), 2945.4 (0) }
[Click to access protein entry]
Spot: 2D-001W8L (nucleoli_hela_2d_human)
pI: 6.57 Mw: 14085
%vol: 0.0533991 %od: 0.0990431
================
*S10AG_HUMAN*
accession n°: Q96FQ6
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1284.6 (0), 1293.7 (0), 1364.7 (0), 1401.6 (0), 1529.7 (0),
1749.9 (0) }
Spot: 2D-001W8L (nucleoli_hela_2d_human)
pI: 6.57 Mw: 14085
%vol: 0.0533991 %od: 0.0990431
================
*S10AG_HUMAN*
accession n°: Q96FQ6
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 1284.6 (0), 1293.7 (0), 1364.7 (0), 1401.6 (0), 1529.7 (0),
1749.9 (0) }
[Click to access protein entry]
Spot: 2D-001W7A (nucleoli_hela_2d_human)
pI: 6.28 Mw: 15233
%vol: 0.0744349 %od: 0.18076
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {PMF}
Spot: 2D-001W7A (nucleoli_hela_2d_human)
pI: 6.28 Mw: 15233
%vol: 0.0744349 %od: 0.18076
================
*H4_HUMAN*
accession n°: P62805
Identification Methods:
* MAPPING: {PMF}
[Click to access protein entry]
Spot: 2D-001VN0 (nucleoli_hela_2d_human)
pI: 6.64 Mw: 47059
%vol: 0.407774 %od: 0.580321
================
*PA2G4_HUMAN*
accession n°: Q9UQ80
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 883.4 (0), 932.5 (0), 984.5 (0), 1054.5 (0), 1125.6 (0),
1182.6 (0), 1278.6 (0), 1294.6 (0), 1366.7 (0), 1391.7 (0), 1407.7 (0),
1629.8 (0), 1651.8 (0), 1816.9 (0), 1832.8 (0), 1927 (0), 2185.1 (0),
2348.2 (0), 2476.3 (0), 3235.8 (0) }
Spot: 2D-001VN0 (nucleoli_hela_2d_human)
pI: 6.64 Mw: 47059
%vol: 0.407774 %od: 0.580321
================
*PA2G4_HUMAN*
accession n°: Q9UQ80
Identification Methods:
* MAPPING: {PMF}
peptide masses: { (TRYPSIN)
$m/Z= 883.4 (0), 932.5 (0), 984.5 (0), 1054.5 (0), 1125.6 (0),
1182.6 (0), 1278.6 (0), 1294.6 (0), 1366.7 (0), 1391.7 (0), 1407.7 (0),
1629.8 (0), 1651.8 (0), 1816.9 (0), 1832.8 (0), 1927 (0), 2185.1 (0),
2348.2 (0), 2476.3 (0), 3235.8 (0) }
[Click to access protein entry]
Spot: 2D-001W0V (nucleoli_hela_2d_human)
pI: 5.27 Mw: 22283
%vol: 0.184469 %od: 0.310558
================
*CBX3_HUMAN*
accession n°: Q13185
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)VEEAEPEEFVVEK(V);; $m/Z=(K)KVEEAEPEEFVVEK(V) }
Spot: 2D-001W0V (nucleoli_hela_2d_human)
pI: 5.27 Mw: 22283
%vol: 0.184469 %od: 0.310558
================
*CBX3_HUMAN*
accession n°: Q13185
Identification Methods:
* MAPPING: {MS/MS}
peptide sequences: {
 $m/Z=(K)VEEAEPEEFVVEK(V);; $m/Z=(K)KVEEAEPEEFVVEK(V) }
![]() |
SWISS-2DPAGE Viewer
|
Back to the![]() |
-Get more information by dragging your mouse pointer over any highlighted spot -Click on a highlighted spot to access all its associated protein entries







































































































Back to the
